Multiparametric MRI and (18)F-PSMA-1007 PET/CT for the Detection of Clinically Significant Prostate Cancer
Prive, B. M., Israel, B., Janssen, M. J. R., van der Leest, M. M. G., de Rooij, M., van Ipenburg, J. A., Jonker, M., Peters, S. M. B., de Groot, M., Zamecnik, P., Hoepping, A., Bomers, J. G., Gotthardt, M., Sedelaar, J. P. M., Barentsz, J. O., van Oort, I. M.,Nagarajah, J.
Implementation of dosimetry for molecular radiotherapy; results from a European survey
Peters, S., Tran-Gia, J., Agius, S., Ivashchenko, O. V., Badel, J. N., Cremonesi, M., Kurth, J., Gabina, P. M., Richetta, E., Gleisner, K. S., Tipping, J., Bardies, M.,Stokke, C.
The EANM Focus 5 consensus on 'molecular imaging and theranostics in prostate cancer': the future begins today
Oprea-Lager, D. E., MacLennan, S., Dierckx, R.,Fanti, S.
European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer
Oprea-Lager, D. E., MacLennan, S., Bjartell, A., Briganti, A., Burger, I. A., de Jong, I., De Santis, M., Eberlein, U., Emmett, L., Fizazi, K., Gillessen, S., Herrmann, K., Heskamp, S., Iagaru, A., Jereczek-Fossa, B. A., Kunikowska, J., Lam, M., Nanni, C., O'Sullivan, J. M., Panebianco, V., Sala, E., Sathekge, M., Sosnowski, R., Tilki, D., Tombal, B., Treglia, G., Tunariu, N., Walz, J., Yakar, D., Dierckx, R., Sartor, O.,Fanti, S.
Quantitative CT imaging and radiation-absorbed dose estimations of (166)Ho microspheres: paving the way for clinical application
Morsink, C., Klaassen, N., van de Maat, G., Boswinkel, M., Arranja, A., Bruggink, R., van Houwelingen, I., Schaafsma, I., Hesselink, J. W., Nijsen, F.,van Nimwegen, B.
[(18)F]PSMA-1007 PET for biochemical recurrence of prostate cancer, a comparison with [(18)F]Fluciclovine
Loeff, C. C., van Gemert, W., Prive, B. M., van Oort, I. M., Hermsen, R., Somford, D. M., Nagarajah, J., Heijmen, L.,Janssen, M. J. R.
Towards effective CAIX-targeted radionuclide and checkpoint inhibition combination therapy for advanced clear cell renal cell carcinoma
Kleinendorst, S. C., Oosterwijk, E., Molkenboer-Kuenen, J., Frielink, C., Franssen, G. M., Boreel, D. F., Tamborino, G., Gloudemans, M., Hendrikx, M., Kroon, D., Hillen, J., Bussink, J., Muselaers, S., Mulders, P., Konijnenberg, M. W., Wheatcroft, M. P., Twumasi-Boateng, K.,Heskamp, S.
Validation of radiolabelled exendin for beta cell imaging by ex vivo autoradiography and immunohistochemistry of human pancreas
Jansen, T. J. P., Tokgoz, S., Buitinga, M., van Lith, S. A. M., Joosten, L., Frielink, C., Smeets, E. M. M., Stommel, M. W. J., van der Kolk, M. B., de Galan, B. E., Brom, M., Boss, M.,Gotthardt, M.
Bone marrow dosimetry in low volume mHSPC patients receiving Lu-177-PSMA therapy using SPECT/CT
Grob, D., Prive, B. M., Muselaers, C. H. J., Mehra, N., Nagarajah, J., Konijnenberg, M. W.,Peters, S. M. B.
Towards the Magic Radioactive Bullet: Improving Targeted Radionuclide Therapy by Reducing the Renal Retention of Radioligands
de Roode, K. E., Joosten, L.,Behe, M.
Improved Localization of Insulinomas Using (68)Ga-NODAGA-Exendin-4 PET/CT
Boss, M., Eriksson, O., Mikkola, K., Eek, A., Brom, M., Buitinga, M., Brouwers, A. H., Velikyan, I., Waser, B., Kauhanen, S., Solin, O., Marciniak, C., Eriksson, B., Reubi, J. C., Aveline, C., Wild, D., Pattou, F., Talbot, J. N., Hofland, J., Sundin, A., Nuutila, P., Hermans, J.,Gotthardt, M.
MHC-I and PD-L1 Expression is Associated with Decreased Tumor Outgrowth and is Radiotherapy-inducible in the Murine Head and Neck Squamous Cell Carcinoma Model MOC1
Boreel, D. F., Sandker, G. G. W., Ansems, M., van den Bijgaart, R. J. E., Peters, J. P. W., Span, P. N., Adema, G. J., Heskamp, S.,Bussink, J.
Inhibition of OXPHOS induces metabolic rewiring and reduces hypoxia in murine tumor models
Boreel, D. F., Beerkens, A. P. M., Heskamp, S., Boswinkel, M., Peters, J. P. W., Adema, G. J., Span, P. N., Bussink, J.
Characterizing OXPHOS inhibitor-mediated alleviation of hypoxia using high-throughput live cell-imaging
Anne P. M. Beerkens, Daan F. Boreel, James A. Nathan, Jiri Neuzil, Gang Cheng, Balaraman Kalyanaraman, Micael Hardy, Gosse J. Adema, Sandra Heskamp, Paul N. Span & Johan Bussink
Radiolabeled Antibodies for Immune Checkpoint PET in Preclinical Research
Boswinkel M, Franssen GM, Heskamp S